GNBT $16 PPS Bargain with Analyst $40 PPS TRGT and Coming Revenue Surprise
November 09 2018 - 10:13AM
InvestorsHub NewsWire
New York, NY-- November 9, 2018 --
InvestorsHub NewsWire -- Generex Biotechnology Corp (OTCQB:
GNBT) has recent analyst coverage with a published
$40 PPS target. The company has
recently realized a high of $25 per share. Last week the
company announced finalizing the acquisition of an operating
company, but the pro-forma financials have not yet
been released. GNBT has great pharmaceutical IP, but little
recent historical revenue. When the pro-forma financials on
the recent acquisition are published per regulatory requirements,
GNBT is likely to realize substantial market attention. With
a $30 million purchase price, the acquired asset is likely to come
with even more annual revenue than the purchase price as purchase
prices for service operations are usually a multiple of margin, not
revenue. When GNBT posts the pro-forma financials or
discloses the acquired revenue in a subsequent events narrative in
its pending quarterly report, the GNBT PPS could top its recent $25
PPS or even push higher toward the analyst $40 PPS target.
The $16 PPS close yesterday looks like a great entry point
today.
Learn more about Generex at http://www.generex.com/
Other PPS movers worth watching include
Puration, Inc. (USOTC:
PURA) reaching a recent $0.25 PPS all time high and pulling
back to $0.10 with what looks like good news on the horizon.
Another potential mover to keep an eye on is Optec International,
Inc. (USOTC:
OPTI) at a $5.00 PPS and having just entered the white hot
urban electric scooter market with Uber, Lyft and now Ford Motor
Company. The final recommendation to watch for today is
Potnetworks (USOTC:
POTN) having just announced extending their substantial online
sales into physical retail.
DISCLAIMER: NextBigTicker.com (NBT)is a
third party publisher and news dissemination service
provider. NBT is NOT affiliated in any manner with any company
mentioned herein. NBT is news dissemination solutions provider and
are NOT a registered broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to sell or offer to buy
any security. NBT's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or
hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted
as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed
financial professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not
occur.
Source: www.nextbigticker.com
Potnetwork (CE) (USOTC:POTN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Potnetwork (CE) (USOTC:POTN)
Historical Stock Chart
From Aug 2023 to Aug 2024